 Atherosclerosis
"Atherosclerosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Descriptor ID |
D050197
|
| MeSH Number(s) |
C14.907.137.126.307
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Atherosclerosis".
Below are MeSH descriptors whose meaning is more specific than "Atherosclerosis".
This graph shows the total number of publications written about "Atherosclerosis" by people in this website by year, and whether "Atherosclerosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 | | 2005 | 0 | 2 | 2 | | 2006 | 7 | 4 | 11 | | 2007 | 6 | 2 | 8 | | 2008 | 6 | 4 | 10 | | 2009 | 12 | 6 | 18 | | 2010 | 9 | 3 | 12 | | 2011 | 6 | 6 | 12 | | 2012 | 9 | 4 | 13 | | 2013 | 15 | 3 | 18 | | 2014 | 14 | 5 | 19 | | 2015 | 12 | 2 | 14 | | 2016 | 17 | 2 | 19 | | 2017 | 7 | 1 | 8 | | 2018 | 11 | 7 | 18 | | 2019 | 13 | 9 | 22 | | 2020 | 10 | 1 | 11 | | 2021 | 14 | 5 | 19 | | 2022 | 20 | 1 | 21 | | 2023 | 17 | 0 | 17 | | 2024 | 12 | 2 | 14 | | 2025 | 12 | 2 | 14 | | 2026 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Atherosclerosis" by people in Profiles.
-
Wang J, Kartiosuo N, Raitakari OT, Viikari J, Juonala M, Bazzano LA, Sinaiko AR, Steinberger J, Daniels SR, Venn AJ, Magnussen C, Woo JG, Ramakrishnan R, Urbina EM, Kähönen M, Jacobs DR, Dwyer T. The association of childhood HDL cholesterol with atherosclerotic cardiovascular disease events in adults: findings from the International Childhood Cardiovascular Cohort Consortium. Eur J Prev Cardiol. 2026 Jul 14; 33(9):1559-1568.
-
Nicholls SJ, Nelson AJ, Ray KK, Ditmarsch M, Kling D, Hsieh A, Szarek M, Kastelein JJ, Davidson MH. Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials. Eur Heart J. 2026 Jul 07; 47(26):3404-3414.
-
Steg PG, Goodman SG, Jukema JW, Martens P, Zirlik A, Bhatt DL, Menon V, Szarek M, Lesogor A, Stratz C, O'Donoghue F, Mena-Madrazo J, Shao Q, Liu K, Mehran R. Design of VICTORION-2 Prevent: A randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease. Am Heart J. 2026 Oct; 300:107493.
-
Hu X, Araujo DS, Khunsriraksakul C, Wang L, Sun Q, Wen J, Zhou L, Ekunwe L, Lange LA, Lange EM, Montgomery SB, Reiner AP, Aguet F, Ardlie KG, Lappalainen T, Gignoux CR, Burchard EG, Taylor KD, Guo X, Rotter JI, Rich SS, Cornell E, Durda P, Tracy RP, Liu Y, Johnson WC, Papanicolaou GP, Perera MA, Cho MH, Liu DJ, Raffield LM, Li Y, Wheeler HE, Im HK, Manichaikul A. Multi-ancestry transcriptome prediction with functionally informed variants in TOPMed MESA improves performance of transcriptome-wide association studies. Am J Hum Genet. 2026 Apr 02; 113(4):828-841.
-
Inia JA, Zhang LH, Keijzer N, Worms N, van Nieuwkoop-van Straalen A, Ditmarsch M, de Kleer M, Jukema JW, Kastelein JJP, Szarek M, van den Hoek AM, Stokman G, Pieterman EJ, Princen HMG. Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background. J Lipid Res. 2026 May; 67(5):101028.
-
Landmesser U, Ray KK, Raal FJ, Garcia Conde L, Han J, Koenig W, Leiter LA, Schwartz GG, Wright RS. Inclisiran in Patients with CKD: Post Hoc Pooled Analysis of Three Phase 3 Trials. J Am Soc Nephrol. 2026 Jul 01; 37(7):1497-1506.
-
Diggs MR, Chu SM, Fitch KV, Olefsky M, Watanabe MG, Erlandson KM, Lu AB, Bloomfield GS, Currier JS, Curran A, Eckard AR, Smith GHR, Sponseller CA, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Foldyna B, Taron J, Karady J, Zanni MV, Douglas PS, Ribaudo HJ, Lu MT, Grinspoon SK. Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial. AIDS. 2026 Apr 01; 40(4):428-439.
-
Liu F, Schrack JA, Walker KA, Walston J, Mathias RA, Griswold ME, Palta P, Windham BG, Jackson JW. The effect of long-term adherence to physical activity recommendations in midlife on plasma proteins associated with frailty in the Atherosclerosis Risk in Communities (ARIC) study. Eur J Epidemiol. 2026 Jan; 41(1):51-69.
-
Wu X, Wilke M, Batara J, Proctor S, Cree M, Ghosh M, Raggi P, Windram J, Becher H, Vine D. Atherogenic ApoB-dyslipidemia, atherosclerotic cardiovascular disease, cardiac dysfunction and remodeling in high-risk young women with and without polycystic ovary syndrome: A pilot study. Front Endocrinol (Lausanne). 2025; 16:1520922.
-
Nicholls SJ, Nelson AJ, Ray KK, Ballantyne CM, Ditmarsch M, Kling D, Hsieh A, Szarek M, Kastelein JJ, Davidson MH. Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis. J Am Coll Cardiol. 2025 Oct 07; 86(14):1046-1056.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|